Effect of L-Carnitine Supplementation associated with muscle sympton, renal anemia and cardiac function in dialysis patients.

Effect of L-Carnitine Supplementation associated with muscle sympton, renal anemia and cardiac function in dialysis patients. - Efffect of L-Carnitine Supplementation in dialysis patients.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007874

Enrollment

Registered

2012-05-14

Start date

2012-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease (dialysis patients)

Interventions

L-Carnitine supplemetation in dailysis patients.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: To be continued dialysis more than one year. To be taken ESA continuously or newly.

Exclusion criteria

Exclusion criteria: allergy of L-Carnitine

Design outcomes

Primary

Measure	Time frame
Improvements of muscle sympton, renal anemia and cardiac function.	—

Countries

Japan

Contacts

Public ContactHiroaki Io

juntendo University Nephrology

chiken@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026